2022-2030 Global and Regional Bacteriophage Therapy Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version

Table Of Contents

Chapter 1 Industry Overview

1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2030)
1.4.2 East Asia Market States and Outlook (2022-2030)
1.4.3 Europe Market States and Outlook (2022-2030)
1.4.4 South Asia Market States and Outlook (2022-2030)
1.4.5 Southeast Asia Market States and Outlook (2022-2030)
1.4.6 Middle East Market States and Outlook (2022-2030)
1.4.7 Africa Market States and Outlook (2022-2030)
1.4.8 Oceania Market States and Outlook (2022-2030)
1.4.9 South America Market States and Outlook (2022-2030)
1.5 Global Bacteriophage Therapy Market Size Analysis from 2022 to 2030
1.5.1 Global Bacteriophage Therapy Market Size Analysis from 2022 to 2030 by Consumption Volume
1.5.2 Global Bacteriophage Therapy Market Size Analysis from 2022 to 2030 by Value
1.5.3 Global Bacteriophage Therapy Price Trends Analysis from 2022 to 2030
1.6 COVID-19 Outbreak: Bacteriophage Therapy Industry Impact
Chapter 2 Global Bacteriophage Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Bacteriophage Therapy (Volume and Value) by Type
2.1.1 Global Bacteriophage Therapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global Bacteriophage Therapy Revenue and Market Share by Type (2017-2022)
2.2 Global Bacteriophage Therapy (Volume and Value) by Application
2.2.1 Global Bacteriophage Therapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global Bacteriophage Therapy Revenue and Market Share by Application (2017-2022)
2.3 Global Bacteriophage Therapy (Volume and Value) by Regions
2.3.1 Global Bacteriophage Therapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Bacteriophage Therapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Bacteriophage Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Bacteriophage Therapy Consumption by Regions (2017-2022)
4.2 North America Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Bacteriophage Therapy Market Analysis
5.1 North America Bacteriophage Therapy Consumption and Value Analysis
5.1.1 North America Bacteriophage Therapy Market Under COVID-19
5.2 North America Bacteriophage Therapy Consumption Volume by Types
5.3 North America Bacteriophage Therapy Consumption Structure by Application
5.4 North America Bacteriophage Therapy Consumption by Top Countries
5.4.1 United States Bacteriophage Therapy Consumption Volume from 2016 to 2021
5.4.2 Canada Bacteriophage Therapy Consumption Volume from 2016 to 2021
5.4.3 Mexico Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 6 East Asia Bacteriophage Therapy Market Analysis
6.1 East Asia Bacteriophage Therapy Consumption and Value Analysis
6.1.1 East Asia Bacteriophage Therapy Market Under COVID-19
6.2 East Asia Bacteriophage Therapy Consumption Volume by Types
6.3 East Asia Bacteriophage Therapy Consumption Structure by Application
6.4 East Asia Bacteriophage Therapy Consumption by Top Countries
6.4.1 China Bacteriophage Therapy Consumption Volume from 2016 to 2021
6.4.2 Japan Bacteriophage Therapy Consumption Volume from 2016 to 2021
6.4.3 South Korea Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 7 Europe Bacteriophage Therapy Market Analysis
7.1 Europe Bacteriophage Therapy Consumption and Value Analysis
7.1.1 Europe Bacteriophage Therapy Market Under COVID-19
7.2 Europe Bacteriophage Therapy Consumption Volume by Types
7.3 Europe Bacteriophage Therapy Consumption Structure by Application
7.4 Europe Bacteriophage Therapy Consumption by Top Countries
7.4.1 Germany Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.2 UK Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.3 France Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.4 Italy Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.5 Russia Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.6 Spain Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.7 Netherlands Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.8 Switzerland Bacteriophage Therapy Consumption Volume from 2016 to 2021
7.4.9 Poland Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 8 South Asia Bacteriophage Therapy Market Analysis
8.1 South Asia Bacteriophage Therapy Consumption and Value Analysis
8.1.1 South Asia Bacteriophage Therapy Market Under COVID-19
8.2 South Asia Bacteriophage Therapy Consumption Volume by Types
8.3 South Asia Bacteriophage Therapy Consumption Structure by Application
8.4 South Asia Bacteriophage Therapy Consumption by Top Countries
8.4.1 India Bacteriophage Therapy Consumption Volume from 2016 to 2021
8.4.2 Pakistan Bacteriophage Therapy Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Bacteriophage Therapy Market Analysis
9.1 Southeast Asia Bacteriophage Therapy Consumption and Value Analysis
9.1.1 Southeast Asia Bacteriophage Therapy Market Under COVID-19
9.2 Southeast Asia Bacteriophage Therapy Consumption Volume by Types
9.3 Southeast Asia Bacteriophage Therapy Consumption Structure by Application
9.4 Southeast Asia Bacteriophage Therapy Consumption by Top Countries
9.4.1 Indonesia Bacteriophage Therapy Consumption Volume from 2016 to 2021
9.4.2 Thailand Bacteriophage Therapy Consumption Volume from 2016 to 2021
9.4.3 Singapore Bacteriophage Therapy Consumption Volume from 2016 to 2021
9.4.4 Malaysia Bacteriophage Therapy Consumption Volume from 2016 to 2021
9.4.5 Philippines Bacteriophage Therapy Consumption Volume from 2016 to 2021
9.4.6 Vietnam Bacteriophage Therapy Consumption Volume from 2016 to 2021
9.4.7 Myanmar Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 10 Middle East Bacteriophage Therapy Market Analysis
10.1 Middle East Bacteriophage Therapy Consumption and Value Analysis
10.1.1 Middle East Bacteriophage Therapy Market Under COVID-19
10.2 Middle East Bacteriophage Therapy Consumption Volume by Types
10.3 Middle East Bacteriophage Therapy Consumption Structure by Application
10.4 Middle East Bacteriophage Therapy Consumption by Top Countries
10.4.1 Turkey Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.3 Iran Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.5 Israel Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.6 Iraq Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.7 Qatar Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.8 Kuwait Bacteriophage Therapy Consumption Volume from 2016 to 2021
10.4.9 Oman Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 11 Africa Bacteriophage Therapy Market Analysis
11.1 Africa Bacteriophage Therapy Consumption and Value Analysis
11.1.1 Africa Bacteriophage Therapy Market Under COVID-19
11.2 Africa Bacteriophage Therapy Consumption Volume by Types
11.3 Africa Bacteriophage Therapy Consumption Structure by Application
11.4 Africa Bacteriophage Therapy Consumption by Top Countries
11.4.1 Nigeria Bacteriophage Therapy Consumption Volume from 2016 to 2021
11.4.2 South Africa Bacteriophage Therapy Consumption Volume from 2016 to 2021
11.4.3 Egypt Bacteriophage Therapy Consumption Volume from 2016 to 2021
11.4.4 Algeria Bacteriophage Therapy Consumption Volume from 2016 to 2021
11.4.5 Morocco Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 12 Oceania Bacteriophage Therapy Market Analysis
12.1 Oceania Bacteriophage Therapy Consumption and Value Analysis
12.2 Oceania Bacteriophage Therapy Consumption Volume by Types
12.3 Oceania Bacteriophage Therapy Consumption Structure by Application
12.4 Oceania Bacteriophage Therapy Consumption by Top Countries
12.4.1 Australia Bacteriophage Therapy Consumption Volume from 2016 to 2021
12.4.2 New Zealand Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 13 South America Bacteriophage Therapy Market Analysis
13.1 South America Bacteriophage Therapy Consumption and Value Analysis
13.1.1 South America Bacteriophage Therapy Market Under COVID-19
13.2 South America Bacteriophage Therapy Consumption Volume by Types
13.3 South America Bacteriophage Therapy Consumption Structure by Application
13.4 South America Bacteriophage Therapy Consumption Volume by Major Countries
13.4.1 Brazil Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.2 Argentina Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.3 Columbia Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.4 Chile Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.5 Venezuela Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.6 Peru Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Bacteriophage Therapy Consumption Volume from 2016 to 2021
13.4.8 Ecuador Bacteriophage Therapy Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Bacteriophage Therapy Business
14.1 Armata Pharmaceuticals, Inc.
14.1.1 Armata Pharmaceuticals, Inc. Company Profile
14.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Specification
14.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Eliava Biopreparations Ltd.
14.2.1 Eliava Biopreparations Ltd. Company Profile
14.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Specification
14.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Pherecydes Pharma
14.3.1 Pherecydes Pharma Company Profile
14.3.2 Pherecydes Pharma Bacteriophage Therapy Product Specification
14.3.3 Pherecydes Pharma Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Intralytix, Inc.
14.4.1 Intralytix, Inc. Company Profile
14.4.2 Intralytix, Inc. Bacteriophage Therapy Product Specification
14.4.3 Intralytix, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Phagelux Inc.
14.5.1 Phagelux Inc. Company Profile
14.5.2 Phagelux Inc. Bacteriophage Therapy Product Specification
14.5.3 Phagelux Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Nextbiotics
14.6.1 Nextbiotics Company Profile
14.6.2 Nextbiotics Bacteriophage Therapy Product Specification
14.6.3 Nextbiotics Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 InnoPhage, Ltd
14.7.1 InnoPhage, Ltd Company Profile
14.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Specification
14.7.3 InnoPhage, Ltd Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Locus Biosciences, Inc.
14.8.1 Locus Biosciences, Inc. Company Profile
14.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Specification
14.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 TechnoPhage
14.9.1 TechnoPhage Company Profile
14.9.2 TechnoPhage Bacteriophage Therapy Product Specification
14.9.3 TechnoPhage Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Eligo Bioscience SA
14.10.1 Eligo Bioscience SA Company Profile
14.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Specification
14.10.3 Eligo Bioscience SA Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Phagomed Biopharma GmbH.
14.11.1 Phagomed Biopharma GmbH. Company Profile
14.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Specification
14.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 PhagePro, Inc.
14.12.1 PhagePro, Inc. Company Profile
14.12.2 PhagePro, Inc. Bacteriophage Therapy Product Specification
14.12.3 PhagePro, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Adaptive Phage Therapeutics, Inc.
14.13.1 Adaptive Phage Therapeutics, Inc. Company Profile
14.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Specification
14.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 EnBiotix, Inc.
14.14.1 EnBiotix, Inc. Company Profile
14.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Specification
14.14.3 EnBiotix, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Intodeworld, Inc.
14.15.1 Intodeworld, Inc. Company Profile
14.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Specification
14.15.3 Intodeworld, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 BiomX Ltd.
14.16.1 BiomX Ltd. Company Profile
14.16.2 BiomX Ltd. Bacteriophage Therapy Product Specification
14.16.3 BiomX Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Phi Therapeutics
14.17.1 Phi Therapeutics Company Profile
14.17.2 Phi Therapeutics Bacteriophage Therapy Product Specification
14.17.3 Phi Therapeutics Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Fixed-phage Ltd.
14.18.1 Fixed-phage Ltd. Company Profile
14.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Specification
14.18.3 Fixed-phage Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Micreos BV
14.19.1 Micreos BV Company Profile
14.19.2 Micreos BV Bacteriophage Therapy Product Specification
14.19.3 Micreos BV Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 ContraFect Corporation
14.20.1 ContraFect Corporation Company Profile
14.20.2 ContraFect Corporation Bacteriophage Therapy Product Specification
14.20.3 ContraFect Corporation Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Bacteriophage Therapy Market Forecast (2022-2030)
15.1 Global Bacteriophage Therapy Consumption Volume, Revenue and Price Forecast (2022-2030)
15.1.1 Global Bacteriophage Therapy Consumption Volume and Growth Rate Forecast (2022-2030)
15.1.2 Global Bacteriophage Therapy Value and Growth Rate Forecast (2022-2030)
15.2 Global Bacteriophage Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2030)
15.2.1 Global Bacteriophage Therapy Consumption Volume and Growth Rate Forecast by Regions (2022-2030)
15.2.2 Global Bacteriophage Therapy Value and Growth Rate Forecast by Regions (2022-2030)
15.2.3 North America Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.4 East Asia Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.5 Europe Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.6 South Asia Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.7 Southeast Asia Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.8 Middle East Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.9 Africa Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.10 Oceania Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.11 South America Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.3 Global Bacteriophage Therapy Consumption Volume, Revenue and Price Forecast by Type (2022-2030)
15.3.1 Global Bacteriophage Therapy Consumption Forecast by Type (2022-2030)
15.3.2 Global Bacteriophage Therapy Revenue Forecast by Type (2022-2030)
15.3.3 Global Bacteriophage Therapy Price Forecast by Type (2022-2030)
15.4 Global Bacteriophage Therapy Consumption Volume Forecast by Application (2022-2030)
15.5 Bacteriophage Therapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology